Insider Transactions in Q4 2022 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2022
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.9%
|
$3,787
$7.75 P/Share
|
|
Dec 01
2022
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,459
-2.07%
|
$10,213
$7.75 P/Share
|
|
Dec 01
2022
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-0.79%
|
$3,787
$7.75 P/Share
|